VOYA Investment Management
TBIO

VOYA Investment Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

VOYA Investment Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-26,882
Closed -$740K – 2846
2021
Q2 		$740K Sell
26,882
-2,853
-10% -$56.1K ﹤0.01% 1847
2021
Q1 		$490K Sell
29,735
-202
-0.7% -$4.6K ﹤0.01% 2051
2020
Q4 		$552K Buy
29,937
+6,981
+30% +$125K ﹤0.01% 1854
2020
Q3 		$312K Buy
22,956
+5,474
+31% +$84.4K ﹤0.01% 1927
2020
Q2 		$313K Sell
17,482
-470
-3% -$7.09K ﹤0.01% 1938
2020
Q1 		$179K Buy
17,952
+1,150
+7% +$9.42K ﹤0.01% 2165
2019
Q4 		$137K Buy
16,802
+4,758
+40% +$43.9K ﹤0.01% 2478
2019
Q3 		$119K Hold
12,044
– – ﹤0.01% 2372
2019
Q2 		$152K Hold
12,044
– – ﹤0.01% 2369
2019
Q1 		$123K Buy
+12,044
New +$92.3K ﹤0.01% 2383

VOYA Investment Management's TBIO Position: Q3 2021 in Review

VOYA Investment Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 26,882 shares — an estimated $740K sold.

VOYA Investment Management first reported a position in TBIO in Q1 2019 and held it in 10 quarters. The position peaked at $740K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • VOYA Investment Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • VOYA Investment Management sold 26,882 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $740K.
  • VOYA Investment Management first reported a position in Translate Bio, Inc. Common Stock in Q1 2019 and held it in 10 quarters.
  • VOYA Investment Management's Translate Bio, Inc. Common Stock position peaked at $740K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on VOYA Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.